Scholars Central

Short communicationPublished 30 May 2022

Development and commercialization of a plasma amino acid based risk diagnosis service

Authors: Takeshi Kimura

Genetics and Molecular Biology Research

Volume 6 · Issue 3 · Pages 2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

From observations indicating that amino acids were a convenient metabolomic subset to investigate changes in metabolism associated with various physiological states, we have developed a technology package (��?AminoIndex technology�) to generate biomarkers using plasma amino acid concentration data, and have commercialized a service based on this technology. In order to achieve commercialization, various problems ranging from sample handling, throughput, standardization and follow-up services had to be overcome and some of these issues, which may be relevant to other biomarker commercialization, will be addressed in the presentation. So far, ��?AminoIndex technology� has been used to generate risk biomarkers for gastric, lung, colorectal, prostate and breast cancer, and more recently for pancratic cancer, and since its launch as a biomarker service in April 2011 in Japan, it has been adopted by over 1000 hospitals and clinics as an optional blood test, and has led to the receipt of various awards in Japan. Research is ongoing to add other cancer risk biomarkers as well as biomarkers for other diseases risks and recent evidence indicate the possibility of generating biomarkers to predict the risk of developing a number of diseases four years in the future. We believe that in the near future, other validated metabolites and omics data could be added to the current analytical platform, increasing discriminative power. Although there are a number of issues still needing refinement, we believe that the ��?AminoIndex technology� platform can play a role in tailor-made nutrition and medicine..

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Genetics and Molecular Biology Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalGenetics and Molecular Biology Research
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Takeshi Kimura”